Karel Petrak, D. Phil
studies in cancer (breast cancer biomarkers),London
University of Sussex, Brighton,Imperial Cancer Research Fund, England
An executive with 40 years experience in pharmaceutical industry, with a demonstrated success in pharmaceutical and biotechnology drug development, drug discovery and delivery of conventional drugs, proteins, and peptides, now seeking to apply industrial experience in basic and translational academic research. Has established a solid record of the NIH SBIR funding
cancer studies, pharmaceutical and biotechnology drug development, drug discovery and delivery of conventional drugs
